In this video, we put Shire‘s (LSE: SHP) deal with AbbVie (NYSE: ABBV) under the spotlight. For each share they held in Shire, investors will receive a cash consideration of £24.44 as well as 0.8960 new AbbVie shares. Here, two Fools look at whether investors should jump into either — or neither — of the pharmaceutical companies.
Inflation is out of control, and people are running scared. But right now there’s one thing we believe Investors should avoid doing at all costs… and that’s doing nothing. That’s why we’ve put together a special report that uncovers 3 of our top UK and US share ideas to try and best hedge against inflation… and better still, we’re giving it away completely FREE today!
